Position
Squarepoint Ops LLC in Immunome Inc.
Back to the book · All holders of IMNM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $11.4K$21.48 → $21.87
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 29.3K | $630.1K | — | — | — | 0.0% |
| Q1 2026 | 67.8K | $1.48M | $21.87 | $11.4K | $840.8K | 0.0% |